The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis
Open accessAbstract
Large multicenter clinical trials have led to two recently approved drugs for patients with idiopathic pulmonary fibrosis (IPF); yet, both of these therapies only slow disease progression and do not provide a definitive cure. Traditionally, preclinical trials have utilized mouse models of bleomycin (BLM)-induced pulmonary fibrosis-though several limitations prevent direct translation to human IPF. Spontaneous pulmonary fibrosis occurs in other animal species, including dogs, horses, donkeys, and cats. While the fibrotic lungs of these animals share many characteristics with lungs of patients with IPF, current veterinary classifications of fibrotic lung disease are not entirely equivalent. Additional studies that profile these examples of spontaneous fibroses in animals for similarities to human IPF should prove useful for both human and animal investigators. In the meantime, studies of BLM-induced fibrosis in aged male mice remain the most clinically relevant model for preclinical study for human IPF. Addressing issues such as time course of treatment, animal size and characteristics, clinically irrelevant treatment endpoints, and reproducibility of therapeutic outcomes will improve the current status of preclinical studies. Elucidating the mechanisms responsible for the development of fibrosis and disrepair associated with aging through a collaborative approach between researchers will promote the development of models that more accurately represent the realm of interstitial lung diseases in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
Travis, W. D., Costabel, U., Hansell, D. M., King, T. E., Lynch, D. A., Nicholson, A. G., Ryerson, C. J., Ryu, J. H., Selman, M., Wells, A. U., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201308-1483st · Cited by 4,290
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Self-citationRaghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916
Ortiz, L. A., Gambelli, F., McBride, C., Gaupp, D., Baddoo, M., Kaminski, N., & Phinney, D. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432929100 · Cited by 1,445
Humanized mice in translational biomedical research
Shultz, L. D., Ishikawa, F., & Greiner, D. L. (2007) · Nature Reviews Immunology · doi:10.1038/nri2017 · Cited by 1,279
Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., & Gauldie, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119590 · Cited by 1,050
Humanized mice in translational biomedical research
Shultz, L. (2007) · The Mouseion at the JAXlibrary (Jackson Laboratory) · Cited by 1,036
Ortiz, L. A., DuTreil, M., Fattman, C., Pandey, A. C., Torres, G., Go, K., & Phinney, D. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704421104 · Cited by 1,019
Moeller, A., Ask, K., Warburton, D., Gauldie, J., & Kolb, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.08.011 · Cited by 1,007
Lee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.809 · Cited by 940
A Mutation in the Surfactant Protein C Gene Associated with Familial Interstitial Lung Disease
Nogee, L. M., Dunbar, A. E., Wert, S. E., Askin, F., Hamvas, A., & Whitsett, J. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440805 · Cited by 929
Bone Marrow–Derived Mesenchymal Stem Cells in Repair of the Injured Lung
Rojas, M., Xu, J., Woods, C. R., Mora, A. L., Spears, W., Roman, J., & Brigham, K. L. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0330oc · Cited by 848
Murine models of pulmonary fibrosis
Moore, B. B., & Hogaboam, C. M. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00313.2007 · Cited by 796
Kolb, M., Margetts, P. J., Anthony, D. C., Pitossi, F., & Gauldie, J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12568 · Cited by 753
Raghu, G., Chen, S.-Y., Yeh, W.-S., Maroni, B., Li, Q., Lee, Y.-C., & Collard, H. R. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70101-8 · Cited by 716
Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance
Hecker, L., Logsdon, N. J., Kurundkar, D., Kurundkar, A., Bernard, K., Hock, T., Meldrum, E., Sanders, Y. Y., & Thannickal, V. J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008182 · Cited by 686 · cited 4×
“Peng et al. performed BLM dose-escalation experiments with mortality rates of 19% with 3 U/kg and 50% with 5 U/kg (28).”
InfluentialWollin, L., Maillet, I., Quesniaux, V., Holweg, A., & Ryffel, B. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.208223 · Cited by 633
Antifibrotic activities of pirfenidone in animal models
Schaefer, C. J., Ruhrmund, D. W., Pan, L., Seiwert, S. D., & Kossen, K. (2011) · European Respiratory Review · doi:10.1183/09059180.00001111 · Cited by 454
Time course of bleomycin‐induced lung fibrosis
Izbicki, G., Segel, M. J., Christensen, T. G., Conner, M. W., & Breuer, R. (2002) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2002.00220.x · Cited by 447
Jenkins, R. G., Moore, B. B., Chambers, R. C., Eickelberg, O., Königshoff, M., Kolb, M., Laurent, G. J., Nanthakumar, C. B., Olman, M. A., Pardo, A., et al. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0096st · Cited by 435
Animal Models of Fibrotic Lung Disease
B. Moore, B., Lawson, W. E., Oury, T. D., Sisson, T. H., Raghavendran, K., & Hogaboam, C. M. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0094tr · Cited by 412
Protection from Pulmonary Fibrosis in the Absence of CCR2 Signaling
Moore, B. B., Paine, R., Christensen, P. J., Moore, T. A., Sitterding, S., Ngan, R., Wilke, C. A., Kuziel, W. A., & Toews, G. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4368 · Cited by 371
Lee, C. G., Cho, S. J., Kang, M. J., Chapoval, S. P., Lee, P. J., Noble, P. W., Yehualaeshet, T., Lu, B., Flavell, R. A., Milbrandt, J., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040104 · Cited by 369
Meiners, S., Eickelberg, O., & Königshoff, M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00186914 · Cited by 340
Chilosi, M., Carloni, A., Rossi, A., & Poletti, V. (2013) · Translational Research · doi:10.1016/j.trsl.2013.06.004 · Cited by 317
Modeling pulmonary fibrosis with bleomycin
Mouratis, M. A., & Aidinis, V. (2011) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328349ac2b · Cited by 311
Self-citationRepetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis
Degryse, A. L., Tanjore, H., Xu, X. C., Polosukhin, V. V., Jones, B. R., McMahon, F. B., Gleaves, L. A., Blackwell, T. S., & Lawson, W. E. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00026.2010 · Cited by 311
Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis
Naikawadi, R. P., Disayabutr, S., Mallavia, B., Donne, M. L., Green, G., La, J. L., Rock, J. R., Looney, M. R., & Wolters, P. J. (2016) · JCI Insight · doi:10.1172/jci.insight.86704 · Cited by 267 · cited 1×
“Mice with targeted deletion of shelterin, a six-protein complex that binds and preserves telomeric repeats, from type alveolar epithelial cells, have been shown to develop spontaneous fibrosis (88, 89).”
BackgroundSime, P. J., Marr, R. A., Gauldie, D., Xing, Z., Hewlett, B. R., Graham, F. L., & Gauldie, J. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65624-6 · Cited by 261
Telomerase and idiopathic pulmonary fibrosis
Armanios, M. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.10.013 · Cited by 245
Future Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report
Blackwell, T. S., Tager, A. M., Borok, Z., Moore, B. B., Schwartz, D. A., Anstrom, K. J., Bar-Joseph, Z., Bitterman, P., Blackburn, M. R., Bradford, W., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201306-1141ws · Cited by 236
Ahluwalia, N., Shea, B. S., & Tager, A. M. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201403-0509pp · Cited by 235
Mice with Pulmonary Fibrosis Driven by Telomere Dysfunction
Povedano, J. M., Martinez, P., Flores, J. M., Mulero, F., & Blasco, M. A. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.028 · Cited by 225 · cited 1×
“Mice with targeted deletion of shelterin, a six-protein complex that binds and preserves telomeric repeats, from type alveolar epithelial cells, have been shown to develop spontaneous fibrosis (88, 89).”
BackgroundPeng, R., Sridhar, S., Tyagi, G., Phillips, J. E., Garrido, R., Harris, P., Burns, L., Renteria, L., Woods, J., Chen, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059348 · Cited by 222
A Role for the Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis
Englert, J. M., Hanford, L. E., Kaminski, N., Tobolewski, J. M., Tan, R. J., Fattman, C. L., Ramsgaard, L., Richards, T. J., Loutaev, I., Nawroth, P. P., et al. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070569 · Cited by 218
Pneumonitis and Emphysema in sp-C Gene Targeted Mice
Glasser, S. W., Detmer, E. A., Ikegami, M., Na, C.-L., Stahlman, M. T., & Whitsett, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210909200 · Cited by 218
Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis
Redente, E. F., Jacobsen, K. M., Solomon, J. J., Lara, A. R., Faubel, S., Keith, R. C., Henson, P. M., Downey, G. P., & Riches, D. W. H. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00122.2011 · Cited by 215
Hoyt, D. G., & Lazo, J. S. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22161-9 · Cited by 198
Mutations in the Surfactant Protein C Gene Associated With Interstitial Lung Disease
Nogee, L. M., Dunbar, A. E., Wert, S., Askin, F., Hamvas, A., & Whitsett, J. A. (2002) · Chest · doi:10.1378/chest.121.3_suppl.20s · Cited by 197
Huang, J., Beyer, C., Palumbo-Zerr, K., Zhang, Y., Ramming, A., Distler, A., Gelse, K., Distler, O., Schett, G., Wollin, L., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-207109 · Cited by 196
Lakatos, H. F., Burgess, H. A., Thatcher, T. H., Redonnet, M. R., Hernady, E., Williams, J. P., & Sime, P. J. (2006) · Experimental Lung Research · doi:10.1080/01902140600817465 · Cited by 174
Aguilar, S., Scotton, C. J., McNulty, K., Nye, E., Stamp, G., Laurent, G., Bonnet, D., & Janes, S. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008013 · Cited by 171
Relaxin deficiency in mice is associated with an age‐related progression of pulmonary fibrosis
Samuel, C. S., Zhao, C., Bathgate, R. A. D., Bond, C. P., Burton, M. D., Parry, L. J., Summers, R. J., Tang, M. L. K., Amento, E. P., & Tregear, G. W. (2003) · The FASEB Journal · doi:10.1096/fj.02-0449fje · Cited by 168
Blue Journal Conference. Aging and Susceptibility to Lung Disease
Thannickal, V. J., Murthy, M., Balch, W. E., Chandel, N. S., Meiners, S., Eickelberg, O., Selman, M., Pardo, A., White, E. S., Levy, B. D., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1876pp · Cited by 166
TLR9 Differentiates Rapidly from Slowly Progressing Forms of Idiopathic Pulmonary Fibrosis
Trujillo, G., Meneghin, A., Flaherty, K. R., Sholl, L. M., Myers, J. L., Kazerooni, E. A., Gross, B. H., Oak, S. R., Coelho, A. L., Evanoff, H., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001510 · Cited by 160
Vicencio, A. G., Lee, C. G., Cho, S. J., Eickelberg, O., Chuu, Y., Haddad, G. G., & Elias, J. A. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0092oc · Cited by 159
Idiopathic Pulmonary Fibrosis: Evolving Concepts
Ryu, J. H., Moua, T., Daniels, C. E., Hartman, T. E., Yi, E. S., Utz, J. P., & LIMPER, A. H. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.03.016 · Cited by 143
Self-citationXing, Z., Tremblay, G. M., Sime, P. J., & Gauldie, J. (1997) · Europe PMC (PubMed Central) · Cited by 139
The Role of Mitochondrial DNA in Mediating Alveolar Epithelial Cell Apoptosis and Pulmonary Fibrosis
Kim, S.-J., Cheresh, P., Jablonski, R. P., Williams, D. B., & Kamp, D. W. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160921486 · Cited by 137
Role of Repeated Lung Injury and Genetic Background in Bleomycin-Induced Fibrosis
Chung, M. P., Monick, M. M., Hamzeh, N. Y., Butler, N. S., Powers, L. S., & Hunninghake, G. W. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0029oc · Cited by 135
Mesenchymal Stromal Cells in Animal Bleomycin Pulmonary Fibrosis Models: A Systematic Review
Srour, N., & Thébaud, B. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0121 · Cited by 135
Role of Endoplasmic Reticulum Stress in Age-Related Susceptibility to Lung Fibrosis
Torres-González, E., Bueno, M., Tanaka, A., Krug, L. T., Cheng, D., Polosukhin, V. V., Sorescu, D., Lawson, W. E., Blackwell, T. S., Rojas, M. M., et al. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0224oc · Cited by 135
Predisposition for Disrepair in the Aged Lung
Sueblinvong, V., Neujahr, D. C., Mills, S. T., Roser‐Page, S., Guidot, D. M., Rojas, M. M., Ritzenthaler, J. D., & Roman, J. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318234c132 · Cited by 135
Viral infection and aging as cofactors for the development of pulmonary fibrosis
Naik, P. K., & Moore, B. B. (2010) · Expert Review of Respiratory Medicine · doi:10.1586/ers.10.73 · Cited by 125
Barbarin, V., Xing, Z., Delos, M., Lison, D., & Huaux, F. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00329.2004 · Cited by 122
Haston, C. K., & Travis, E. L. (1997) · PubMed · Cited by 119
Lee, C. G., Kang, H.-R., Homer, R., Chupp, G. L., & Elias, J. A. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200602-017aw · Cited by 116
Anti-Inflammatory Effects of Adult Stem Cells in Sustained Lung Injury: A Comparative Study
Moodley, Y. P., Vaghjiani, V., Chan, J. M. K., Baltic, S., Ryan, M., Tchongue, J., Samuel, C. S., Murthi, P., Parolini, O., & Manuelpillai, U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069299 · Cited by 116
Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice
Liu, T., Chung, M. J., Ullenbruch, M. R., Yu, H., Jin, H., Hu, B., Choi, Y. Y., Ishikawa, F., & Phan, S. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32369 · Cited by 113
Relaxin-1–deficient mice develop an age-related progression of renal fibrosis
Samuel, C. S., Zhao, C., BOND, C. P., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00628.x · Cited by 110
Persistent overexpression of interleukin-1beta and tumor necrosis factor-alpha in murine silicosis.
Davis, G. S., Pfeiffer, L., & Hemenway, D. R. (1998) · PubMed · Cited by 100
Pierce, E. M., Carpenter, K. J., Jakubzick, C., Kunkel, S. L., Flaherty, K. R., Martínez, F. J., & Hogaboam, C. M. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060649 · Cited by 92
Epigenetics in idiopathic pulmonary fibrosis
Tzouvelekis, A., & Kaminski, N. (2015) · Biochemistry and Cell Biology · doi:10.1139/bcb-2014-0126 · Cited by 92
Self-citationTelomerase in alveolar epithelial development and repair
Driscoll, B., Buckley, S., Bui, K. C., Anderson, K. D., & Warburton, D. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1191 · Cited by 90
Christensen, P. J., Goodman, R. E., Pastoriza, L., Moore, B. B., & Toews, G. B. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65493-4 · Cited by 87
Lee, S. H., Lee, E. J., Lee, S. Y., Kim, J. H., Shim, J. J., Shin, C., In, K. H., Kang, K. H., Uhm, C. S., Kim, H. K., et al. (2014) · Experimental Lung Research · doi:10.3109/01902148.2014.881930 · Cited by 83
Markers of macrophage differentiation in experimental silicosis
Misson, P., van den Brûle, S., Barbarin, V., Lison, D., & Huaux, F. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0104019 · Cited by 81
Update on therapeutic management of idiopathic pulmonary fibrosis
Spagnolo, P., Τzouvelekis, Α., & Bonella, F. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s69716 · Cited by 78
Inheritance of susceptibility to bleomycin-induced pulmonary fibrosis in the mouse.
Haston, C. K., Amos, C. I., King, T. M., & Travis, E. L. (1996) · PubMed · Cited by 76
Characterization of the Effect of Interleukin-10 on Silica-Induced Lung Fibrosis in Mice
Barbarin, V., Arras, M., Misson, P., Delos, M., McGarry, B. M., Phan, S. H., Lison, D., & Huaux, F. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0299oc · Cited by 73
Identification of Spontaneous Feline Idiopathic Pulmonary Fibrosis
Williams, K. J., Malarkey, D. E., Cohn, L. A., Patrick, D. J., Dye, J. A., & Toews, G. (2004) · CHEST Journal · doi:10.1378/chest.125.6.2278 · Cited by 72
Self-citationPhase-directed therapy: TSG-6 targeted to early inflammation improves bleomycin-injured lungs
Foskett, A. M., Bazhanov, N., Ti, X., Tiblow, A., Bartosh, T. J., & Prockop, D. J. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00240.2013 · Cited by 71
Lymphocytes, Lymphokines, and Silicosis
Davis, G. S., Holmes, C. E., Pfeiffer, L. M., & Hemenway, D. R. (2001) · Journal of Environmental Pathology Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.v20.isuppl.1.50 · Cited by 67
Telomerase deficiency does not alter bleomycin-induced fibrosis in mice
Degryse, A. L., Xu, X. C., Newman, J., Mitchell, D. B., Tanjore, H., Polosukhin, V. V., Jones, B. R., McMahon, F. B., Gleaves, L. A., Phillips, J. A., et al. (2012) · Experimental Lung Research · doi:10.3109/01902148.2012.658148 · Cited by 59
Combined Tlr2 and Tlr4 Deficiency Increases Radiation-Induced Pulmonary Fibrosis in Mice
Paun, A., Fox, J., Balloy, V., Chignard, M., Qureshi, S. T., & Haston, C. K. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.12.065 · Cited by 57
Interferon-γ Production by Specific Lung Lymphocyte Phenotypes in Silicosis in Mice
Davis, G. S., Pfeiffer, L. M., & Hemenway, D. R. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.4.3599 · Cited by 56
Naik, P. K., Horowitz, J. C., Moore, T. A., Wilke, C. A., Toews, G. B., & Moore, B. B. (2011) · The Journals of Gerontology Series A · doi:10.1093/gerona/glr211 · Cited by 52
SH2 Domain–Containing Phosphatase-2 Is a Novel Antifibrotic Regulator in Pulmonary Fibrosis
Tzouvelekis, A., Yu, G., Cardenas, C. L. L., Herazo‐Maya, J. D., Wang, R., Woolard, T., Zhang, Y., Sakamoto, K., Lee, H., Yi, J.-S., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201602-0329oc · Cited by 52
Self-citationPersonalized medicine in idiopathic pulmonary fibrosis: facts and promises
Spagnolo, P., Τzouvelekis, Α., & Maher, T. M. (2015) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000187 · Cited by 51
Selman, M., Buendía-Roldán, I., & Pardo, A. (2016) · Revista de investigaci�n Cl�nica · doi:10.1016/s0034-8376(25)00211-6 · Cited by 50
Translational models of lung disease
Mercer, P. F., Abbott-Banner, K., Adcock, I. M., & Knowles, R. G. (2014) · Clinical Science · doi:10.1042/cs20140373 · Cited by 49
A novel model for human interstitial lung disease: Hapten‐driven lung fibrosis in rodents
Roberts, S., Howie, S., Wallace, W. A., Brown, D. M., Lamb, D., Ramage, E., & Donaldson, K. (1995) · The Journal of Pathology · doi:10.1002/path.1711760313 · Cited by 47
Paun, A., & Haston, C. K. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.08.004 · Cited by 44
Ganciclovir Antiviral Therapy in Advanced Idiopathic Pulmonary Fibrosis: An Open Pilot Study
Egan, J. J., Adamali, H. I., Lok, S., Stewart, J. P., & Woodcock, A. A. (2011) · Pulmonary Medicine · doi:10.1155/2011/240805 · Cited by 44
Expansion of Interferon-γ –Producing Lung Lymphocytes in Mouse Silicosis
Davis, G. S., Pfeiffer, L. M., & Hemenway, D. R. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.4.3407 · Cited by 44
Baur, X., Hj, W., Budnik, L. T., Egilman, D. S., Oliver, C., Frank, A. L., Soskolne, C. L., Landrigan, P. J., & Lemen, R. A. (2017) · American Journal of Industrial Medicine · doi:10.1002/ajim.22709 · Cited by 42
Chronic Pleuropulmonary Fibrosis and Elastosis of Aged Donkeys
Miele, A., Dhaliwal, K., du Toit, N., Murchison, J. T., Dhaliwal, C. A., Brooks, H. W., Smith, S. H., Hirani, N., Schwarz, T., Haslett, C., et al. (2014) · CHEST Journal · doi:10.1378/chest.13-1306 · Cited by 35
Noninvasive Monitoring of Pulmonary Fibrosis by Targeting Matrix Metalloproteinases (MMPs)
Cai, Y., Zhu, L., Zhang, F., Niu, G., Lee, S., Kimura, S., & Chen, X. S. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300613x · Cited by 33
Biomarkers in the Evaluation and Management of Idiopathic Pulmonary Fibrosis
Τzouvelekis, Α., Herazo‐Maya, J. D., Sakamoto, K., & Bouros, D. E. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666150930120959 · Cited by 33
A novel segmental challenge model for bleomycin-induced pulmonary fibrosis in sheep
Organ, L. A., Bacci, B., Koumoundouros, E., Barcham, G., Kimpton, W. G., Nowell, C. J., Samuel, C. S., & Snibson, K. J. (2014) · Experimental Lung Research · doi:10.3109/01902148.2014.985806 · Cited by 30
Idiopathic Pulmonary Fibrosis: Recent Trials and Current Drug Therapy
Jones, M. G., Fletcher, S., & Richeldi, L. (2013) · Respiration · doi:10.1159/000356958 · Cited by 28
Protective and therapeutic effect of felodipine against bleomycin-induced pulmonary fibrosis in mice
Tanaka, K., Niino, T., Ishihara, T., Takafuji, A., Takayama, T., Kanda, Y., Sugizaki, T., Tamura, F., Kurotsu, S., Kawahara, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03676-y · Cited by 27
Padilla-Carlin, D. J., Schladweiler, M. C. J., Shannahan, J. H., Kodavanti, U. P., Nyska, A., Burgoon, L. D., & Gavett, S. H. (2011) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2011.586940 · Cited by 26
Mouse genetic approaches applied to the normal tissue radiation response
Haston, C. K. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00094 · Cited by 25
Long-Term Response of Rats to Single Intratracheal Exposure of Libby Amphibole or Amosite
Cyphert, J. M., Padilla-Carlin, D. J., Schladweiler, M. C. J., Shannahan, J. H., Nyska, A., Kodavanti, U. P., & Gavett, S. H. (2012) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2012.641203 · Cited by 23
Stefanov, A. N., Fox, J., & Haston, C. K. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003203 · Cited by 23
Idiopathic pulmonary fibrosis: on the move
Bouros, D. E., & Τzouvelekis, Α. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70240-6 · Cited by 21
AQX‐1125, small molecule SHIP1 activator inhibits bleomycin‐induced pulmonary fibrosis
Cross, J. L., Stenton, G. R., Harwig, C., Szabó, C., Genovese, T., Paola, R. D., Esposito, E., Cuzzocrea, S., & Mackenzie, L. F. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13934 · Cited by 21
Activation of telomerase by silica in rat lung
Kim, J.-K., Lim, Y., Kim, K., Seo, M.-S., Kim, J., Lee, K.-H., & Park, C. Y. (2000) · Toxicology Letters · doi:10.1016/s0378-4274(99)00195-2 · Cited by 20
Τzouvelekis, Α., Tzilas, V., Papiris, S. A., Aidinis, V., & Bouros, D. E. (2016) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2016.12.002 · Cited by 20
Self-citationQUANTITATIVE IMAGE ANALYSIS OF LUNG CONNECTIVE TISSUE IN MURINE SILICOSIS
Antonini, J. M., Hemenway, D. R., & Davis, G. S. (2000) · Experimental Lung Research · doi:10.1080/019021400269880 · Cited by 19
Pathology of Asbestosis: An Update of the Diagnostic Criteria Response to a Critique
Roggli, V. L., Gibbs, A. R., Attanoos, R. L., et al. (2016) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2015-0503-sa · Cited by 17
Li, J., Poovey, H. G., Rodriguez, J. F., Brody, A. R., & Hoyle, G. W. (2004) · Journal of Environmental Pathology Toxicology and Oncology · doi:10.1615/jenvpathtoxoncol.v23.i4.20 · Cited by 16
Genetic variation and dynamics of infections of equid herpesvirus 5 in individual horses
Back, H., Ullman, K., Leijon, M., Söderlund, R., Penell, J. C., Ståhl, K., Pringle, J. K., & Valarcher, J. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000332 · Cited by 15
Update on models of pulmonary fibrosis therapy for preclinical drug research
Antoniu, S. A., & Kolb, M. R. J. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903186100 · Cited by 7
Asbestos activates CH12.LX B-lymphocytes via macrophage signaling
Rasmussen, D. L., & Pfau, J. C. (2011) · Journal of Immunotoxicology · doi:10.3109/1547691x.2011.631953 · Cited by 5
Cited by
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
Moss, B. J., Ryter, S. W., & Rosas, I. O. (2022) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-030240 · Cited by 821
Inflammation and immunity in IPF pathogenesis and treatment
Heukels, P., Moor, C. C., von der Thüsen, J. H., Wijsenbeek, M. S., & Kool, M. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2018.12.015 · Cited by 517
Dual inhibition of αvβ6 and αvβ1 reduces fibrogenesis in lung tissue explants from patients with IPF
Decaris, M. L., Schaub, J. R., Chen, C., Cha, J., Lee, G. G., Rexhepaj, M., Ho, S. S., Rao, V., Marlow, M. M., Kotak, P., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01863-0 · Cited by 94
The Development of Serum Amyloid P as a Possible Therapeutic
Pilling, D., & Gomer, R. H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02328 · Cited by 92
“A simple non-surgical animal model of a fibrosing disease is pulmonary fibrosis in mice and rats, where a drug called bleomycin can be pipetted through the mouth into the airway, and within 14 days causes pulmonary fibrosis (112, 113).”
BackgroundPan, H., Deutsch, G. H., Wert, S. E., Subcommittee, O. B. O. T. O., Ambalavanan, N., Ansong, C., Ardini-Poleske, M. E., Bagwell, J., Chan, C., Deutsch, G. H., et al. (2019) · Journal of Biomedical Semantics · doi:10.1186/s13326-019-0209-1 · Cited by 73
Metadata
- Authors
- Tashiro, J., Rubio, G. A., Limper, A. H., Williams, K., Elliot, S. J., Ninou, I., Aidinis, V., Tzouvelekis, A., & Glassberg, M. K.
- Venue
- Frontiers in Medicine
- Publisher
- Frontiers Media SA
- Published
- 2017-07-28
- Volume
- 4
- Pages
- 118-118
- ISSN
- 2296-858X (ISSN-L)
- OpenAlex
- W2739715566
- Cited by
- 314
- References
- 108
- FWCI
- 15.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.